Cargando…
Results from an international multicenter trial evaluating the ease-of-use of and preference for a newly developed disposable injection pen for the treatment of growth hormone deficiency in treatment-naïve children and adults
Previous research has reported that ease of use of and preference for a delivery device are associated with greater patient compliance – an important factor in achieving optimal therapeutic results. The objective of this study was to assess the ease-of-use of a new disposable pen (GoQuick(®), Pfizer...
Autores principales: | Pleil, Andreas M, Darendeliler, Feyza, Dörr, Helmuth G, Hutchinson, Katherine, Wollmann, Hartmut A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990392/ https://www.ncbi.nlm.nih.gov/pubmed/24748824 http://dx.doi.org/10.2147/MDER.S59821 |
Ejemplares similares
-
Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
por: Pleil, Andreas M, et al.
Publicado: (2012) -
Ease of Use, Preference, and Safety of the Recombinant Human Growth Hormone Disposable Pen Compared with the Reusable Device: A Multicenter, Single-Arm, Open-Label, Switch-Over, Prospective, Phase IV Trial
por: Lee, Ji-Eun, et al.
Publicado: (2019) -
Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes
por: Pohlmeier, Harald, et al.
Publicado: (2017) -
Disposal of Used Pens and Needles from Diabetes Patients Perspective
por: Catic, Tarik, et al.
Publicado: (2020) -
Patient Reported Ease-of-Use with a Disposable Autoinjector in Individuals with Migraine
por: Mead, Jennifer, et al.
Publicado: (2020)